Mini Review Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.33696/Gastroenterology.1.001
Hepatitis Treatment in the Last 20 Years: A Short Review
Abdurrahman Sagir1,*
- 1Academic Teaching Hospital Bethesda Duisburg, Department of Gastroenterology, Heerstr. 219, 47053 Duisburg, Germany
Corresponding Author
Abdurrahman Sagir, a.sagir@bethesda.de
Received Date: March 23, 2020
Accepted Date: March 30, 2020
Sagir A. Hepatitis Treatment in the Last 20 Years: A Short Review. Arch Gastroenterol Res. 2020; 1(1): 1-3.
Copyright: © 2020 Sagir A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Archives of Gastroenterology Research: A Message from Prof. Dr. Rolf Teschke (Editor-in-Chief)
As the new editor-in-chief of Archives of Gastroenterology Research (AGR) I cordially welcome all current readers of AGR and future contributors to AGR. Together with my editorial team of AGR we encourage scientists and clinicians involved in the care of patients with gastrointestinal diseases to submit their interesting reports to AGR with the aim to be published following fair evaluation by external peer reviewers
Sofosbuvir/Velpatasvir/Voxilaprevir for Previously DAA-treated Patients with Chronic Hepatitis C?
Chronic hepatitis C infection is a global public health problem affecting more than 71 million people. Treatment of hepatitis C virus (HCV) has rapidly advanced with the introduction of oral direct-acting antivirals (DAAs).
Review of Renal Transplantation of Hepatitis C Viremic Donor Organs into Aviremic Recipients
The development of direct-acting antiviral agents for the treatment of Hepatitis C (HCV) has changed the practice of treating patients with HCV. In particular, organ transplant recipients who have not previously been exposed to HCV are now able to consider receiving an organ from a donor who is infected with HCV, and anticipate effective antiviral therapy after transplantation.